Mini-brains' grown in the lab allow scientists to study brain wiring without interfering with brains in living people, and ...

The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...

PALI-2108 is the first and only PDE4 inhibitor in development targeting the terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...

South Korea's SeaWith has signed a supply deal with the UK's 3D Bio-Tissues, whose cell culture media can reduce the cost of ...

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

As a proof of concept, the engineers then used the same system to convert acetyl-CoA into malate, a commercially valuable ...

Life may have emerged from a surprisingly simple network of chemical reactions long before cells or genes existed.

About Secura Bio, Inc. Secura Bio is an integrated, commercial-stage pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies for physicians ...

Palisade Bio's PALI-2108 could be a game-changer for gut health with strong upside potential. Read here for an investment analysis of PALI stock.